SCHEMBL20744749

SCHEMBL20744749

Nc1ncnc2c1c(Oc1cc(Cl)ccn1)nn2C1CC(O)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.60
CYP3A4 P08684 3/20 0.60
CYP2D6 P10635 3/20 0.60
CYP2C9 P11712 3/20 0.60
CYP2C19 P33261 3/20 0.60
KDR P35968 11/20 0.44
SRC P12931 9/20 0.44
RET P07949 4/20 0.44
CSNK1A1 P48729 2/20 0.44
CSNK1D P48730 2/20 0.44
CDC7 O00311 1/20 0.44
PLK4 O00444 1/20 0.44
DYRK3 O43781 1/20 0.44
JAK2 O60674 1/20 0.44
PRKD3 O94806 1/20 0.44
MAP4K4 O95819 1/20 0.44
NTRK1 P04629 1/20 0.44
INSR P06213 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22944629 1.00 CYP1A2 (0.60) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20744791 0.90 CYP1A2 (0.74) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20754229 0.90 CYP1A2 (0.74) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20744746 0.89 CYP1A2 (0.72) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20744767 0.88 CYP1A2 (0.67) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL24005685 0.86 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20744779 0.85 CYP1A2 (0.82) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20754329 0.85 CYP1A2 (0.82) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20744782 0.85 CYP1A2 (0.82) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL21806812 0.80 CYP1A2 (0.74) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668875-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2020-06-24 EP disclosed
WO-2019036001-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2019-02-21 WO disclosed